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BACKGROUND: Acute myocardial infarction (AMI) is the most common cause of death in the world. One preventive attempt to reduce AMI is 
early detection of blood lipid profile. A simple method of 
lipid profile assessment is the measurement of atherogenic 
index of plasma (AIP), meanwhile more accurate 
method of lipid profile assessment is the measurement of 
apolipoprotein B/apolipoprotien A-I (ApoB/ApoAI) ratio. 
However, whether both measurements are interchangeable 
is need to be investigated. This study aims to investigate 
the correlation between AIP value and ApoB/ApoAI ratio in 
patients with AMI. 
METHODS: The study design was cross-sectional study. 
The blood samples of consecutively enrolled AMI patients 
had been selected after inclusion and exclusion criteria. 
The blood samples were taken within 24 hours of patient 
admission to the hospital. The blood concentration of 
high-density lipoprotein (HDL) and triglycerides (TG) 
were measured using turbidimetric method. The AIP 
was calculated as logarithmic of TG/HDL ratio (log10.
[TG:HDL]) The concentration of ApoB and ApoAI 
were measured using immunoturbidimetric method. The 
correlation between these measurements was analyzed with 
Pearson correlation test. 
RESULTS:  The blood samples of 76 subjects were 
collected and analyzed. The subjects were dominated by 
male (n=67, 88%)  and those whose age ≥55 years old 
(n=54, 71%). The mean ApoB value was 88.66 mg/dL and 
ApoAI was 97.39 mg/dL. The AIP value was 0.05. The 
Pearson correlation test between AIP and ApoB/ApoAI ratio 
showed a significant positive correlation with the strength of 
correlation was moderate (r=0.51, p-value<0.01). 
CONCLUSION: There was a significantly positive and 
moderate correlation between AIP value and ApoB/ApoAI 
ratio in acute myocardial infarction patients. 
KEywORDS: apolipoprotein B/apolipoprotein A-I ratio, 
atherogenic index of plasma, acute myocardial infarction
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Abstract
Introduction
Ischemic heart disease is the most common cause of death in 
both men and women worldwide.(1) In Indonesia, ischemic 
heart disease is on the top seven cause of death or contributes 
of 5.1% of crude mortality rate.(2) Acute myocardial 
infarction (AMI) is the damage of cardiac muscles because 
of severe or prolonged ischemic.(3) AMI is the result of 
an atherosclerotic plaque rupture and thrombosis which is 
blocking the coronary blood vessel that leads to deficiency 
of blood supply for myocardium.(4)
 Heart disease risk can be detected by measurement 
of lipid level in blood. In 1970, lipoprotein compound was 
found and considered more specific. The first measurement 
of low density lipoprotein (LDL) and high density 
lipoprotein (HDL) cholesterols was done in late 1970.(5) 
The calculation of lipid level in blood is commonly done 
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in the laboratory setting by calculating total cholesterol and 
triglycerides (TG).(6) Various indices (total cholesterol/
HDL, LDL/HDL and HDL/LDL) are used as the reference 
value of heart disease risk. In 2000, Dobiasova and Frohlich 
introduced an index called the atherogenic index of plasma 
(AIP). In the calculations, AIP also counts TG, so it has a 
better predictive value in determining cardiovascular risk 
factors than other indices.(7)
 Lee and Alaupovic are the first researchers who 
stated that lipoprotein can be differentiated into smaller 
protein particle called apolipoprotein.(8) A case control 
study by Kwiterovich, et al., showed that apolipoprotein 
ratio, specifically Apolipoprotein B/Apolipoprotein 
A-I (ApoB/ApoAI) ratio could be used as risk factor 
determinant for coronary artery disease (CAD) patients.(9) 
According to Kaneva, et al., ApoB/ApoAI ratio is the most 
superior plasma atherogenicity marker.(10) However, the 
measurement ApoB/ApoAI is more difficult and expensive 
than AIP. The latter is rely on the routine examination of 
lipid profile ubiquitously used in every hospital laboratory. 
Dabiasova had classified AIP value into three categories for 
cardiovascular risk, i.e., low risk ((-0.3) – 0.1), intermediate 
risk (0.1 – 0.24) and high risk (>0.24).(11) Based on the 
ApoB/ApoA-I ratio, there is also risk classification for 
cardiovascular events, with value >0.90 for males and 
>0.80 for females as high risk.(12,13) This study aims to 
investigate the correlation between ApoB/ApoAI ratio and 
AIP value in patients with AMI. 
Methods
This research was designed as cross-sectional study, and was 
approved  by  Ministry  of  Education  and  Culture Faculty 
of Medicine Gadjah Mada University Medical and Health 
Research Ethics Comittee (MHREC), No: KE/FK/817/EC. 
The  data  of  this  current  research  was  extracted  from 
the  main  research  case  report  form,  already  published 
elsewhere.(14,15)  
 The selected subjects were AMI patients treated in 
Intensive Cardiac Care Unit (ICCU) of Dr. Sardjito General 
Hospital, Yogyakarta, Indonesia and fulfilled the research 
criteria. Inclusion criteria of this research were: 1) patients 
diagnosed with AMI based on two of three criteria i.e., 
clinically: angina specific chest pain, electrocardiography: 
elevation of ST or depression of ST or T inverted, and 
laboratory: increasing of troponin I cardiac enzyme and/
or creatine kinase-MB (CK-MB); 2) patients with the chest 
pain onset not more than 72 hours; 3) patients with age 18-
75 years; and 4) patients with ability to give an informed 
consent to participate in the research voluntarily. The 
exclusion criteria of this research were: 1) patients with 
stage V chronic kidney disease, chronic heart failure with 
The New York Heart Association (NYHA) functional class 
≥ II, heart valve disease and hepatic cirrhosis; 2) patients 
with acute comorbidity, i.e., acute stroke, acute infection, 
sepsis, chronic inflammation disease, diabetes mellitus and 
vena thromboembolic; and 3) patients with malignancy.
 Research subjects were enrolled with consecutive 
methods. The subjects’ demographic data (age, sex, 
smoking history, hypertension disease history, diabetes 
mellitus, previous heart disease, and lipid abnormality), 
clinical data (systole and diastole blood pressure and 
heart rate frequency), and laboratory data (lipid profile 
examination such as total cholesterol, TG, HDL, LDL, 
ApoB, and ApoA-I) were recorded. Blood samples 
were withdrawn within 24-hour admission in the ICCU 
under fasting condition. Lipid examination was done to 
determine the total cholesterol, TG, LDL cholesterol, and 
HDL cholesterol using turbidimetric method in hospital 
laboratory. The measurement of ApoB and ApoAI was 
performed with Hitachi 902 automated imunoturbidimetric 
method (Diamond Diagnostic, Holliston, USA).
 For statistics analysis, the normality test was done 
to find data distribution pattern (the Kolmogorov Smirnov 
test). Based on data distribution pattern the correlation test 
was performed with Pearson correlation test. The p-value of 
0.05 was set as a significant limit.
Results
The number of subjects analyzed were 76 patients. Table 
1 shows the characteristic of subjects. The AMI patients 
were dominated by male (88%), and most of subjects’ age 
was ≥55 years old (71%). The most dominant diagnose was 
myocardial infarct with ST-segment elevation (STEMI) 
which comprised of 71% subjects. Most of patients had 
background as active smokers (53%) and hypertension 
(72%).
 The mean ApoB value was 88.66 mg/dL and mean 
ApoA-I was 97.39. Overall results showed that mean 
value of ApoB/ApoAI ratio was 0.92. According to risk 
classification, the value of  ApoB/ApoAI ratio was in high 
risk classification. The mean AIP value was 0.05, which 
was low risk according to risk stratification based on AIP. 
The finding of low AIP value was resulted from normal 
HDL value and low TG which caused the low ratio of TG/
HDL. Table 2 shows the mean value of apolipoprotein, lipid 
profile, ApoB/ApoAI ratio and AIP.
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Sex Males 67 (88.20%)
Females 9 (11.80%)
Age <55 years 22 (28.90%)
≥55 years 54 (71.10%)
AMI Diagnostic STEMI 54 (71.10%)
NSTEMI 22 (28.90%)
Smoking status Never smoke 20 (26.30%)
Ex-smokers 15 (19.70%)
Smokers 41 (53.90%)
Hypertension Yes 55 (72.40%)
No 21 (21.60%)
Characteristic Frequencies,  n (%)
Table 1.  The subjects demography characteristics  (n=76).
AMI: Acute Myocardial Infarction; STEMI: ST-elevation 
Myocardial Infarction; NSTEMI: Non ST-Elevation 
Myocardial Infarction
ApoB (mg/dL) 88.66 32.90 149.00 88.43 90.34 0.89
ApoAI (mg/dL) 97.39 55.00 130.00 96.79 101.89 0.39
Total Cholesterol (mg/dL) 176.78 86.00 273.00 175.34 187.56 0.37
Triglyceride (mmol/L) 1.24 0.54 2.34 1.24 1.27 0.81
HDL (mmol/L) 1.07 0.49 1.68 1.05 1.21 0.06
LDL (mmol/L) 3.04 1.11 5.21 3.02 3.22 0.53
LDL/HDL 2.95 1.14 4.90 2.98 2.77 0.55
ApoB/ApoAI 0.92 0.46 1.37 0.93 0.86 0.48
AIP 0.05 -0.38 0.42 0.06 0.00 0.44
Females
p -value*
Mean
Mean Minimum Value
Maximum 
Value Males
Variables
ApoB : Apolipoprotein-B, ApoAI : Apolipoprotein A-I, HDL : High Density Lipoprotein, LDL : Low Density Lipoprotein, 
AIP : Atherogenic Index of Plasma. *p-value for comparison between males and females, tested with independent Student 
T-test. 
Table 2. The mean value of apoliprotein and lipid profile among subjects.
 The ApoB/ApoAI ratio was significantly correlated 
with lipid profile parameters, i.e., total cholesterol (r=0.57, 
p-value<0.01), TG (r=0.40, p-value<0.01), HDL cholesterol 
(r=-0.40, p-value<0.01) and LDL cholesterol (r=0.63, 
p-value<0.01). For the AIP, the correlation was significant 
with ApoB (r=0.35, p-value<0.01) and LDL cholesterol 
(r=0.24, p-value<0.01). Table 3 shows the correlation 
among apolipoprotein and lipid profile with ApoB/ApoAI 
ratio and AIP.
 The ApoB/ApoAI ratio had moderate positive and 
significant  correlation  with  AIP  value.  The  r  value  was 
0.51 with p-value<0.01. The Figure 1 shows the scatter 
plot of the correlation between AIP value and ApoB/ApoAI 
ratio.
Discussion
In this study, there was a significantly positive and moderate 
correlation between AIP value and ApoB/ApoAI ratio. 
Among subjects with AMI, AIP value did not indicate the 
high risk classification for cardiovascular event. In contrast, 
the ApoB/ApoAI ratio indicated high risk for cardiovascular 
disease. Indeed, the subjects were those who had undergone 
cardiovascular event, i.e., AMI. The gender, male and 
female, did not affect this  high  risk classification based on 
the ApoB/ApoAI ratio.  
 AMI is a clinical syndrome caused by coronary artery 
occlusion. In result of that occlusion, the decrease of oxygen 
flow to cardiac muscle cell (ischemia) induces a muscle 
cell death (necrosis) in the supplied area.(16) Muscle 
cell necrosis is influenced by the time of coronary artery 
occlusion.(17) According to Willerson, et al., AMI occurs 
at minimum 20 minutes after cardiac muscle cell does not 
receive oxygen supply.(3)
 Atherosclerotic in coronary artery is the most important 
part of AMI disease development. It is initiated with LDL 
deposition in intimal layer of coronary artery and formation 
a fibrous cap lesion that can easily rupture. Once ruptured, 
it promotes the development of intracoronary thrombosis. 
(16) When thrombosis spread and block the arterial blood 
flow, it will cause cardiac muscle ischemia in distal area of 
obstruction. If the event happens in a severe and long time, 
it can induce cardiac muscle necrosis or infarct. (16)
 AIP is a logarithm of TG ratio and HDL (log10 
TG/HDL). Both have molar unit. Research analysis of 
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Table 3. The correlation among apolipoprotein and lipid profile with ApoB/ApoAI ratio and AIP .
ApoB : Apolipoprotein-B; ApoAI : Apolipoprotein A-I; HDL : High Density Lipoprotein; 
LDL: Low Density Lipoprotein; AIP: Atherogenic Index of Plasma. *tested with Pearson 
correlation test.
r value
ApoB 0.78 <0.01 0.35 <0.01
ApoA-I -0.22 N.S -0.19 N.S
Total Cholesterol 0.57 <0.01 0.16 N.S
Triglyceride 0.40 <0.01 0.84 <0.01
HDL -0.40 <0.01 -0.70 <0.01
LDL 0.63 <0.01 0.24 <0.01
Variables
ApoB/ ApoAI
r value p- value*
AIP
p- value*
0.60
0.40
0.20
0
-0.20
-0.40
A
th
er
og
en
ic
 In
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x 
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sm
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0.40 0.60 0.80 1.00 1.20 1.40
Apolipoprotein B/Apolipoprotein A-I Ratio
(r= 0.51; p<0.01)
Figure 1. The scatter plot of correlation between ApoB/ApoAI 
ratio and AIP value.
Dobiasova and Frohlich in 1156 subjects, showed that 
AIP was recommended as the most sensitive index to 
determine  profile  of  plasma  atherogenicity  as  risk  factor 
of heart disease.(7) In another study, AIP proved to have 
higher sensitivity (84%) than other indexes such as total 
cholesterol/HDL (68%), HDL/LDL (73%), LDL/HDL 
(76%). Specificity of AIP is 99%, equivalent with other 
indexes.(18) In the group without the risk (children, healthy 
females, etc.), AIP value is 0 or negative. In the group with 
the risk (males and menopause females), and group with 
high risk (diabetic patients, hyperkeratosis lenticularis 
perstans (HLP) patients, patients with positive angiography 
and AMI) AIP increased to positive value.(7)  Our study 
shows that the subjects had low risk classification for 
cardiovascular event based on AIP value. However based 
on ApoB/ApoAI ratio, subjects had high risk classification 
for cardiovascular event. 
 In  study  conducted  by  McQueen,  et al.,  it  was 
concluded  that  ApoB/ApoAI  ratio  in  patients  who  did 
not  fast,  was  more  superior  than  other  cholesterol 
indexes in determine  the  AMI  risk  in  all  range  of 
age,  sex,  and ethnics.(19)  Other  study by Kaneva, et 
al., showed that ratio of ApoB/ApoAI value was the most 
superior marker  for  determining  plasma  atherogenicity 
rather than traditional lipid marker and new few markers 
such as ApoE and AIP.(10)
 The mean value of AIP in this study classified as low 
risk, different with the mean ApoB/ApoAI ratio which 
classified as high risk. However, both were sufficiently 
correlated. The AIP value can not represent ApoB/ApoAI 
ratio.  Further  research  will  be  needed  to  assess 
compatibility of risk categories and interaction of both 
indexes, including influence of risk factors (age, sex, 
lipoprotein level, and TG level) towards AIP and ApoB/
ApoAI ratio. This is corresponding with study by Kaneva, 
et al., which showed positive correlation between AIP and 
ApoB/ApoAI ratio.(10) However, overall AIP value can not 
represent ApoB/ApoAI ratio. According to Kaneva, et al., 
AIP only represented qualitative lipoprotein composition, 
whereas ApoB/ApoAI ratio showed quantitative lipoprotein 
composition. (10)
 The limitation of this study were:  1) there was no 
control of dyslipidemia drugs consumption; 2) history of 
subjects’ previous lipid profiles were unknown; and 3) the 
number of females subjects was unbalanced with males. 
Further  research  will  be  needed  to  corroborate  our 
finding. 
Print ISSN: 2085-3297, Online ISSN: 2355-9179The Indonesian Biomedical Journal, Vol.10, No.2, August 2018, p.179-83
183
Conclusion
The conclusion of this study is there is a significantly positive 
and moderate correlation between the ApoB/ApoA-I ratio 
with AIP in patients with acute myocardial infarction.
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